Regentis Biomaterials Ltd. (RGNT)

Is Regentis Biomaterials Ltd. (RGNT) A Buy Now?

According to our latest analysis, RGNT could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on RGNT, as trading bearish markets can be challenging and may result in losses.

1. RSI (Relative Strength Index): The RSI(14) value of 38.22 indicates that RGNT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
2. STOCH (Stochastic Oscillator): The STOCH value of 21.97 indicates that RGNT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 100.00 indicates that RGNT is overbought. This suggests that RGNT price is at or near the highest level relative to its recent price history.
4. ADX (Average Directional Index): The ADX value of 17.30 suggests that there may be some movement in price, but it lacks strength or conviction.
5. CCI (Commodity Channel Index): A CCI(14) value of -11.23 indicates that RGNT is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term RGNT price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Regentis Biomaterials Ltd. financial reports and earnings history, Regentis Biomaterials Ltd. (RGNT) stock could reach $22.90 by 2030, $77.98 by 2040 and $139.18 by 2050. See the projected annual prices until 2050 of the Regentis Biomaterials Ltd. stock below:

• Regentis Biomaterials Ltd. (RGNT) is expected to reach an average price of $15.77 in 2035, with a high prediction of $47.38 and a low estimate of $8.34. This indicates an +1,051% change from the last recorded price of $1.37.
• Regentis Biomaterials Ltd. (RGNT) stock is projected to chart a bullish course in 2040, with an average price target of $37.05, representing an +2,604% change from its current level. The forecast ranges from a conservative $14.40 to a sky-high $77.98.
• Our analysts predict Regentis Biomaterials Ltd. (RGNT) to change +4,887% by 2045, soaring from $20.46 to an average price of $68.32, potentially reaching $108.58. While $20.46 is the low estimate, the potential upside is significant.
• Regentis Biomaterials Ltd. (RGNT) stock is expected to climb by 2050, reaching an average of $106.04, a +7,640% change from its current level. However, a wide range of estimates exists, with high and low targets of $139.18 and $26.52, respectively, highlighting the market's uncertainty.

Regentis Biomaterials Ltd. Stock (RGNT) Year by Year Forecast